[Ongoing clinical trials by vascular statin, cerivastatin].
Tomita
N
N
Department of General Medicine, Osaka University Hospital.
Morishita
R
R
Ogihara
T
T
D001161:Arteriosclerosis / Q000209:etiology / Q000517:prevention & control; D003327:Coronary Disease / Q000209:etiology / Q000517:prevention & control*; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000097:blood; D004730:Endothelium, Vascular / Q000166:cytology / Q000502:physiology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000188:drug therapy* / Q000209:etiology; D008055:Lipids / Q000097:blood; D011725:Pyridines / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids; D011725:Pyridines; C086276:cerivastatin